Drug Database
Back to search

United Kingdom· GB-APID-10070411000001106

Brevibloc Concentrate 2.5g/10ml solution for infusion ampoules

A esmolol product containing esmolol, registered in United Kingdom by Baxter Healthcare Ltd. The same ATC class is registered in 16 of our 19 countries.

ATC C07AB09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBrevibloc Concentrate 2.5g/10ml solut…ATCC07AB09REGISTER NO.GB-APID-1007041100000…PACKS LISTED0CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about esmololAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Esmolol is registered in 16 of 19 countries.

Countries holding a registration under ATC C07AB09 (esmolol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose
Search esmolol products by name

Esmolol · ATC C07AB09

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Esmolol
Manufacturer
Baxter Healthcare Ltd
Country
United Kingdom (GB)
ATC code
C07AB09
ATC class
Esmolol
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for esmolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check esmolol against other medicinesHow interaction checks work

Esmolol · interactions on record

196 records

  • 11 severe
  • 139 moderate
  • 8 minor

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe

38 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Esmolol in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All esmolol products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Brevibloc, Esmolol Amomed
  • Belgium · Brevibloc
  • Cyprus · Brevibloc, Esmobeta
  • Czechia · Esmocard, Esmocard Lyo
  • Germany · Brevibloc, Esmocard
  • Denmark · Brevibloc
  • Spain · Brevibloc, Esmolol Aurovitas
  • Finland · Brevibloc
  • France · Brevibloc, Esmocard
  • Greece · Brevibloc, Esmobeta
  • Croatia · Esmocard
  • Ireland · Brevibloc Premixed
  • Italy · Brevibloc, Esmocard
  • Luxembourg · Brevibloc
  • Malta · Brevibloc Premixed
  • Netherlands · Brevibloc, Esmolol Hcl Hikma
  • Norway · Brevibloc
  • Portugal · Brevibloc, Esmolol Eugia
  • Sweden · Brevibloc
  • Slovenia · Esmocard, Esmocard Lyo
  • Slovakia · Esmocard, Esmocard Lyo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a2054f0c-1208-4176-8d0a-cbc22f546f9d
GET /v1/drugs/a2054f0c-1208-4176-8d0a-cbc22f546f9d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10070411000001106",
  "desc": "Brevibloc Concentrate 2.5g/10ml solution for infusion ampoules (Baxter Healthcare Ltd)",
  "form": "Solution for infusion",
  "vpid": "35893411000001103",
  "source": "dmd",
  "vtm_id": "775833007",
  "strength": "250 mg",
  "substance": "Esmolol",
  "ingredient": "Esmolol hydrochloride",
  "supplier_code": "2063601000001104"
}
API referenceMCP serverPlans

See everything about esmolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console